The Wegovy pill (OASIS 4 trial) enrolled 307 adults living with obesity, or with excess weight plus a weight-related condition, and without type 2 diabetes
Understanding its molecular structure and handling requirements will help you get the most out of the compound in your research
Wegovy frequently causes nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
If you are a day late, use that as an opportunity to focus more intently on your protein intake, hydration, and movement
Mitochondrial dysfunction in depression
I needed surgery and then spent six weeks in a wheelchair. Who would guess that a snapped Achilles tendon could be the consequence of treating bronchitis with an antibiotic